Sivelestat for lung protection during emergency aortic surgery
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether a drug called sivelestat can protect your lungs and other organs during emergency surgery for a very serious aortic tear. If you qualify, you would receive the drug or a placebo right before and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Type A acute aortic syndrome (a serious tear in the main artery from the heart) within the last 2 weeks.
- You are scheduled to have emergency heart or aorta surgery.
- You are between 18 and 90 years old.
- You agree to join the study and sign a consent form.
- You are not allergic to the study drug sivelestat sodium.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two anti-inflammatory drugs, ulinastatin and thymosin α1, can help protect your immune system and organs after emergency surgery for a torn aorta (aortic dissection). If you qualify and take part, you may receive these medications in addition to standard care.
This trial studies a specific surgical approach using branched stents to repair multiple damaged parts of the upper (thoracic) aorta. It may help people who need urgent or complex aortic repair and are expected to survive more than two years.
This trial is studying treatments for people with a sudden tear in the main artery from the heart (type A aortic dissection) or a similar condition. It aims to improve outcomes after this emergency.
This trial tests whether using artificial intelligence to guide treatment choices can improve recovery in people with a sudden tear in the main artery (aortic dissection). All participants will receive emergency surgery, but the AI may help doctors tailor the approach to each person's condition, potentially reducing complications.
This study tests whether an “add-on” anti-inflammatory approach can help after surgery for certain problems affecting the aorta (the body’s main artery) soon after symptoms begin. It may be designed to reduce inflammation-related complications in people who are treated quickly and can join follow-up.
This study tests whether a drug called sivelestat can help protect your organs after surgery for a type A aortic dissection. It may reduce inflammation and improve recovery.
Hear when a new Aortic Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.